Waystar's Strong Growth and AI Push vs. Rich Valuation and Leverage

What happened

Waystar's recent subscription growth accelerated to 34% year-over-year, helping drive total revenue growth of 18% and an adjusted EBITDA margin of 42.8%, according to a new Seeking Alpha article. These results build on the company's established AI-driven platform and the integration of Iodine Software, which management believes expands the addressable market by over 15% and supports cross-selling. However, the article notes net revenue retention of 108%, down from the 110.1% reported in the company's latest filings, suggesting a slight slowdown in existing customer expansion. The DeepValue master report had previously flagged the stock as richly valued, trading at ~58x trailing earnings and ~13.5x EV/EBITDA with net debt to EBITDA of 3.5x, and the new data does not materially alter that view. While operating momentum is positive, the elevated valuation and balance-sheet leverage continue to leave limited margin of safety, warranting continued caution.

Implication

Waystar's accelerating subscription growth and expanding margins affirm the strength of its sticky, data-rich platform and the potential of its AI initiatives. Yet the stock's premium valuation—roughly 66% above DCF-implied value—already prices in flawless execution, leaving little room for error. The slight decline in net revenue retention from 110.1% to 108% may be an early sign of market saturation or competitive pressure, and should be monitored closely. High leverage at 3.5x net debt/EBITDA and modest interest coverage magnify sensitivity to rate movements and operational missteps, especially as the company integrates Iodine. Investors should await a better entry point, perhaps near or below the DCF estimate, or clear evidence of deleveraging and sustained high retention before reassessing to a buy.

Thesis delta

The new data reinforces Waystar's strong operational execution, particularly in subscription growth and margin expansion, but the slight dip in net revenue retention and persistent overvaluation do not change the overall investment stance. The master report's WAIT judgment remains valid; the new information is insufficient to justify a buy at current prices, though continued strength could eventually support a more constructive view.